Moderna awarded tender for COVID-19 vaccine
Moderna Receives EU Tender Order for Covid-19 Vaccine
Moderna on Friday said it received approval for supplying its Spikevax Covid-19 vaccine to the European Union, Norway and North Macedonia following a tender process. Under the agreement, 17 participating countries could order an updated version of the biotech company's mRNA Covid-19 vaccine for up to four years.
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...
The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...
Representatives of Moderna Biotech UK and NHS England will also be questioned by the inquiry, led by crossbench peer Baroness ...
As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.
The company's newer product, an RSV ( respiratory syncytial virus) vaccine, has also underperformed, contributing "minimal ...
Watch live as Kemi Badenoch gives evidence to the UK Covid inquiry on Wednesday, 27 January. The inquiry will also hear from ...
The agency had for years said it could not conclude whether COVID-19 was the result of a lab incident or it originated in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback